Covered recipient · General Payments record
TIMOTHY S SHAVER
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2023
$1,770.78
- Reported across 116 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $450.88 | 37 |
| Education | $19.62 | 1 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $226.91 | 25 |
| Novo Nordisk AS | $56.92 | 3 |
| Abbott Laboratories | $43.64 | 2 |
| Lilly USA, LLC | $40.27 | 2 |
| Bayer HealthCare Pharmaceuticals Inc. | $32.71 | 2 |
| GlaxoSmithKline, LLC. | $21.11 | 1 |
| ITI, Inc. | $19.24 | 1 |
| Acerta Pharma LLC | $16.42 | 1 |
| Xeris Pharmaceuticals, Inc. | $13.28 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (38)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $21.79 | 02/01/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1018647419 | CMS |
| Abbott Laboratories | $21.85 | 04/03/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1018478625 | CMS |
| AbbVie Inc. | $5.84 | 02/01/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998956869 | CMS |
| AbbVie Inc. | $5.45 | 02/22/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998956873 | CMS |
| AbbVie Inc. | $20.41 | 03/07/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998956877 | CMS |
| AbbVie Inc. | $15.31 | 03/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998956881 | CMS |
| AbbVie Inc. | $20.64 | 03/28/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998956885 | CMS |
| AbbVie Inc. | $18.43 | 04/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998956889 | CMS |
| AbbVie Inc. | $5.49 | 04/25/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998956893 | CMS |
| AbbVie Inc. | $6.06 | 05/09/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998956897 | CMS |
| AbbVie Inc. | $7.35 | 05/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998956901 | CMS |
| AbbVie Inc. | $7.39 | 05/22/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998956905 | CMS |
| AbbVie Inc. | $7.92 | 06/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998956909 | CMS |
| AbbVie Inc. | $5.83 | 06/12/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998956913 | CMS |
| AbbVie Inc. | $7.35 | 06/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998956917 | CMS |
| AbbVie Inc. | $12.13 | 06/28/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998956921 | CMS |
| AbbVie Inc. | $5.67 | 06/29/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998956925 | CMS |
| AbbVie Inc. | $6.37 | 07/11/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998956929 | CMS |
| AbbVie Inc. | $7.19 | 07/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998956933 | CMS |
| AbbVie Inc. | $8.33 | 07/24/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998956937 | CMS |
| AbbVie Inc. | $16.93 | 08/01/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998956941 | CMS |
| AbbVie Inc. | $5.43 | 08/17/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998956945 | CMS |
| AbbVie Inc. | $7.03 | 08/22/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998956949 | CMS |
| AbbVie Inc. | $6.10 | 09/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998956953 | CMS |
| AbbVie Inc. | $5.45 | 10/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998956957 | CMS |
| AbbVie Inc. | $6.10 | 11/02/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998956961 | CMS |
| AbbVie Inc. | $6.71 | 11/29/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998956965 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.42 | 01/11/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1014492354 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $13.09 | 04/24/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1000056537 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $19.62 | 05/01/2023 | Education | Undisputed | 01/23/2026 | 1000133421 | CMS |
| GlaxoSmithKline, LLC. | $21.11 | 03/22/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002977615 | CMS |
| ITI, Inc. | $19.24 | 01/26/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1040697491 | CMS |
| Lilly USA, LLC | $13.28 | 02/13/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1032371085 | CMS |
| Lilly USA, LLC | $26.99 | 04/24/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1032239265 | CMS |
| Novo Nordisk Inc | $22.50 | 01/24/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1001883497 | CMS |
| Novo Nordisk Inc | $19.11 | 02/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1001883487 | CMS |
| Novo Nordisk Inc | $15.31 | 05/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1001883477 | CMS |
| Xeris Pharmaceuticals, Inc. | $13.28 | 03/01/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1056513117 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.